Author Archives: Zinnia Jones

About Zinnia Jones

My work focuses on insights to be found across transgender healthcare, public health, psychiatry, and history of medicine, integrating these many perspectives and guided by the lived experiences of trans people. I live in Orlando with my family, and work mainly in technical writing.

Large study of trans people in the Netherlands shows growing numbers seeking treatment, low regret rates

Medical transition by trans people, its prevalence and demographics, and rates of regret of treatment are perennial subjects of public curiosity and media controversy. With unfortunate frequency, this has taken the form of scaremongering that depicts the growing numbers of … Continue reading

Posted in Health care, Outcomes of transition, Regret and detransition, Statistics and demographics, Trans youth | Leave a comment

Transgender depersonalization testimonies around the web, 2018

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Throughout numerous articles, I’ve covered many aspects of the experience of chronic depersonalization among trans people, a condition of persistent feelings of unreality or having “no self” that’s especially common in … Continue reading

Posted in Awareness building, Depersonalization, Gender dysphoria, Psychology and psychiatry | Leave a comment

Bad trip: What trans people should know about cannabis and depersonalization

Previously: Depersonalization in gender dysphoria: widespread and widely unrecognized Substance abuse is highly prevalent in the transgender population, and is known to be associated with psychosocial risk factors such as stigma, discrimination, and trauma (Glynn & van den Berg, 2017). … Continue reading

Posted in Depersonalization, Psychology and psychiatry, Sociological research | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision. Summary Cyproterone acetate (CPA) is commonly used as … Continue reading

Posted in Endocrinology, Oncology, Transgender medicine | Leave a comment

4thWaveNow “ROGD parent” Brie Jontry doesn’t know what histrelin is

4thWaveNow, one of the three survey respondent recruitment sites for the badly flawed study of an alleged new “rapid onset gender dysphoria” condition, has long served as a clearinghouse for questionable notions about puberty-blocking medications used for transgender youth. These … Continue reading

Posted in Endocrinology, Health care, Trans youth | Leave a comment